Valuation check: GNFT's profit margin is -8.07%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2025
Trailing 12 months ending Jun 2025
The latest profit margin for GNFT is -8.07% as of June 2025. That compares with -111.3% in the prior-year period — up 92.7% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Genfit's historical trend and sector peers before judging valuation or financial health.
Over the past year, GNFT's profit margin moved from -111.3% to -8.07% — a 92.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Genfit's valuation or profitability profile.
Against Healthcare companies, GNFT currently prints -8.07% for profit margin, while the sector average sits near 13.89%. That is roughly 158.1% below the sector mean. Large gaps often invite a closer look at Genfit's growth, margins, and balance sheet.
Profit Margin shows how effectively Genfit converts resources into returns. At -8.07%, GNFT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -111.3% in the prior-year period — up 92.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GNFT's profit margin (-8.07%), review year-over-year change from -111.3%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.